Cargando…

N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world, and due to its complex pathogenic factors, its prognosis is poor. N6-methyladenosine (m(6)A) RNA methylation plays an important role in the tumorigenesis, progression, and prognosis of many tumors. The m(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Jihao, Zhou, Minglei, Xu, Jianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364031/ https://www.ncbi.nlm.nih.gov/pubmed/34389000 http://dx.doi.org/10.1186/s12957-021-02354-8

Ejemplares similares

SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition
por: Zhang, Yuanping, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) RNA methylation regulators are associated with clinical prognosis in hepatocellular carcinoma
por: Li, Gao, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) methylation in ischemia–reperfusion injury
por: Yao, Weifeng, et al.
Publicado: (2020)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2021)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model
por: Zhang, Yue, et al.
Publicado: (2021)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

Construction and validation of an N6-methyladenosine-associated prognostic signature in hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2021)

Identification and Characterization of Alcohol-related Hepatocellular Carcinoma Prognostic Subtypes based on an Integrative N6-methyladenosine methylation Model: Erratum
por: Zhang, Yue, et al.
Publicado: (2022)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

mRNA N(6)-methyladenosine methylation of postnatal liver development in pig
por: He, Shen, et al.
Publicado: (2017)

N6-methyladenosine mRNA methylation is important for the light response in soybean
por: Zhang, Liya, et al.
Publicado: (2023)

Dual effects of N(6)-methyladenosine on cancer progression and immunotherapy
por: Li, Hui, et al.
Publicado: (2021)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

Transcriptome-wide N6-methyladenosine (m(6)A) methylation in watermelon under CGMMV infection
por: He, Yanjun, et al.
Publicado: (2021)

Comprehensive Analysis of N(6)-Methyladenosine (m(6)A) Methylation in Neuromyelitis Optica Spectrum Disorders
por: Yang, Hong, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
por: Xu, Qianhui, et al.
Publicado: (2021)

YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs
por: Roundtree, Ian A, et al.
Publicado: (2017)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

Comprehensive Analysis of N6-Methyladenosine (m(6)A) RNA Methylation Regulators and Tumour Microenvironment Cell Infiltration Involving Prognosis and Immunotherapy in Gastroesophageal Adenocarcinomas
por: Liu, Duanrui, et al.
Publicado: (2022)

Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke
por: Zhang, Fangfang, et al.
Publicado: (2022)

Our views of dynamic N(6)-methyladenosine RNA methylation
por: Zhao, Boxuan Simen, et al.
Publicado: (2018)

N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)

Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer
por: Lin, Gaoteng, et al.
Publicado: (2021)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma
por: Huang, Zhilong, et al.
Publicado: (2022)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

Profiling of RNA N(6)-Methyladenosine Methylation Reveals the Critical Role of m(6)A in Chicken Adipose Deposition
por: Cheng, Bohan, et al.
Publicado: (2021)

N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis
por: Xie, Furong, et al.
Publicado: (2022)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2n09osqd6kb946v8c4scspjfvv